First-Mover Advantage: How Generic Drug Makers Win Big by Launching First
The first generic manufacturer to launch a drug after patent expiry captures up to 90% of the market share and maintains a lasting advantage due to pharmacy stocking habits, prescriber loyalty, and patient inertia. This edge is built into U.S. drug law and persists for years.